FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of Check out FDAs new roster of bulk drug substances being pulled from use in compounding. Youll see BPC 157 and TB 500 among the various peptides added to the list of category 2 substances FDA Peptide Ban Lifted: Legit Compounding Pharmacies Now Regulate Julian Becerra posted on the topic LinkedIn The Pharmacology of Longevity: Peptide Edition (Part 1) FDA to Consider Lifting Restrictions on Numerous Compounded Peptides Foley & Lardner FDA Removes Key Peptides from Category 2: What This Means for You